Items where Funder is Seres Therapeutics Inc.

A1332

Normington, C, Moura, IB orcid.org/0000-0002-3019-7196, Byrant, JA et al. (10 more authors) (2021) Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection. npj Biofilms and Microbiomes, 7. 16. ISSN 2055-5008

Normington, C., Moura, I. orcid.org/0000-0002-3019-7196, Byrant, J. et al. (4 more authors) (2022) Sessile Clostridioides difficilecontribute towards recurrent C. difficileinfection. Access Microbiology, 4 (5). ISSN 2516-8290

NO EXT REF GIVEN

Normington, C, Moura, IB orcid.org/0000-0002-3019-7196, Byrant, JA et al. (10 more authors) (2021) Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection. npj Biofilms and Microbiomes, 7. 16. ISSN 2055-5008

Normington, C., Moura, I. orcid.org/0000-0002-3019-7196, Byrant, J. et al. (4 more authors) (2022) Sessile Clostridioides difficilecontribute towards recurrent C. difficileinfection. Access Microbiology, 4 (5). ISSN 2516-8290

Not Given

Beauchemin, N., Halvorsen, E., Hicks, N. et al. (20 more authors) (2025) Sa1770: CHARACTERIZATION OF IBD MICROBIOMES IN MODELS OF MICROBIOME DISRUPTION AND INFLAMMATION TO EVALUATE CANDIDATE BIOMARKERS FOR PATIENT SELECTION. In: Gastroenterology. DDW 2025, 03-06 May 2025, San Diego, USA. Elsevier , S-523-S-523.

Not Known

Beauchemin, N., Halvorsen, E., Hicks, N. et al. (20 more authors) (2025) Sa1770: CHARACTERIZATION OF IBD MICROBIOMES IN MODELS OF MICROBIOME DISRUPTION AND INFLAMMATION TO EVALUATE CANDIDATE BIOMARKERS FOR PATIENT SELECTION. In: Gastroenterology. DDW 2025, 03-06 May 2025, San Diego, USA. Elsevier , S-523-S-523.

Normington, C, Moura, IB orcid.org/0000-0002-3019-7196, Byrant, JA et al. (10 more authors) (2021) Biofilms harbour Clostridioides difficile, serving as a reservoir for recurrent infection. npj Biofilms and Microbiomes, 7. 16. ISSN 2055-5008